172 related articles for article (PubMed ID: 34637053)
21. (R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study.
Collignon A; Houillier C; Ahle G; Chinot O; Choquet S; Schmitt A; Agape P; Soussain C; Hoang-Xuan K; Tabouret E
Ann Hematol; 2019 Apr; 98(4):915-922. PubMed ID: 30535802
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma.
Yang Y; Li Q; Ma J; Kang H; Lin Z; Wang Y; Ma Y; Chen B
Front Oncol; 2023; 13():1098785. PubMed ID: 37182159
[TBL] [Abstract][Full Text] [Related]
23. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B; Xia R
Front Immunol; 2023; 14():1191033. PubMed ID: 37426647
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
Velasco R; Mercadal S; Vidal N; Alañá M; Barceló MI; Ibáñez-Juliá MJ; Bobillo S; Caldú Agud R; García Molina E; Martínez P; Cacabelos P; Muntañola A; García-Catalán G; Sancho JM; Camro I; Lado T; Erro ME; Gómez-Vicente L; Salar A; Caballero AC; Solé-Rodríguez M; Gállego Pérez-Larraya J; Huertas N; Estela J; Barón M; Barbero-Bordallo N; Encuentra M; Dlouhy I; Bruna J; Graus F;
J Neurooncol; 2020 Jul; 148(3):545-554. PubMed ID: 32524392
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and prognostic analysis of 30 cases of primary central nervous system lymphoma].
She C; Tan L; Li P; Ma L; Li W
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):282-5. PubMed ID: 25916286
[TBL] [Abstract][Full Text] [Related]
27. Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry.
Burns EA; Sanchez CG; Mathur S; Guerrero C; Muhsen IN; Sarfraz H; Hu CA; Tang CA; Shah SS; Tremont IW; Teh B; Ganguly S; Pingali SRK
Ann Hematol; 2023 May; 102(5):1111-1120. PubMed ID: 36922432
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
Liu Y; Yao Q; Zhang F
Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
[TBL] [Abstract][Full Text] [Related]
29. Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment.
Zhang Y; Zhang Q; Wang XX; Deng XF; Zhu YZ
Clin Radiol; 2016 Oct; 71(10):1018-1029. PubMed ID: 27341986
[TBL] [Abstract][Full Text] [Related]
30. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
31. Primary central nervous system lymphoma: age and performance status are more important than treatment modality.
Corry J; Smith JG; Wirth A; Quong G; Liew KH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):615-20. PubMed ID: 9635710
[TBL] [Abstract][Full Text] [Related]
32. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Chamberlain MC; Kormanik P; Glantz M
Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.
Schuurmans M; Bromberg JE; Doorduijn J; Poortmans P; Taphoorn MJ; Seute T; Enting R; van Imhoff G; van Norden Y; van den Bent MJ
Br J Haematol; 2010 Oct; 151(2):179-84. PubMed ID: 20738305
[TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
35. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
36. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Kasenda B; Ferreri AJ; Marturano E; Forst D; Bromberg J; Ghesquieres H; Ferlay C; Blay JY; Hoang-Xuan K; Pulczynski EJ; Fosså A; Okoshi Y; Chiba S; Fritsch K; Omuro A; O'Neill BP; Bairey O; Schandelmaier S; Gloy V; Bhatnagar N; Haug S; Rahner S; Batchelor TT; Illerhaus G; Briel M
Ann Oncol; 2015 Jul; 26(7):1305-13. PubMed ID: 25701456
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
38. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of gamma-knife surgery-incorporated systemic chemotherapy omitting whole brain radiotherapy for the treatment of elderly primary central nervous system lymphoma patients with poor prognostic scores.
Cho J; Kim J; Ryu HJ; Roh HG; Chung HW; Koh YC; Lee MH; Ko YH; Kim SY
Med Oncol; 2014 Mar; 31(3):863. PubMed ID: 24496562
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
Wang H; Wang M; Wei J; Wang L; Mao L; Jin J
J Int Med Res; 2018 Feb; 46(2):883-894. PubMed ID: 28984175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
